Matches in SemOpenAlex for { <https://semopenalex.org/work/W995825909> ?p ?o ?g. }
- W995825909 abstract "<p>Multiple sclerosis (MS) is an immune-mediated disease in which self-reacting T lymphocytes enter the central nervous system (CNS) and direct the damage of the myelin sheaths, which protect nerve axons. While there is no cure for MS currently, specific disease-modifying therapies are available that target the relapsing-remitting form of MS. However, these therapies are not effective in progressive forms of MS, which affect ~50% of MS patients in New Zealand, and thus there is an urgent need for novel treatments to be developed to treat these patients. MIS416 is a microparticle, which targets phagocytic cells by activating cytosolic receptors NOD2 and Toll-like receptor 9, and has recently completed a phase 2a trial in the treatment of progressive MS with promising results. The aim of this thesis was to elucidate the mechanism(s) by which MIS416 modified autoimmune disease using an animal model of MS, experimental autoimmune encephalomyelitis (EAE). We determined that weekly intravenous doses of MIS416 were effective at reducing disease in a chronic model of MS, EAE, and we used this dosing regimen to further understand mechanisms involved in MIS416-induced EAE protection. It was found that MIS416 treatment induced a number of peripheral immune changes which had the potential to alter a T cell-mediated autoimmune disease, including increased levels of serum NO and IFN-γ, increased numbers of Tregs and macrophages as well as increased expression of PD-L1, an anti-proliferative ligand. Additionally, we also determined that MIS416 treatment significantly reduced T cell proliferation in vitro and in vivo. To investigate which of these peripheral changes were involved in MIS416-mediated protection from EAE, we assessed each change individually in our disease model. We found that the central immune-modulating factor responsible for the protective effects of MIS416 treatment was IFN-γ (White, Webster, O'Sullivan, Stone, & La Flamme, 2014) as IFN-γ-/- mice treated with MIS416 were not protected from EAE. This protective role of MIS416-induced IFN-γ was likely to have been mediated through downstream effects given that in the absence of IFN-γ many of these changes were not seen. In particular, the macrophage population did not expand in MIS416-treated IFN-γ-/- mice, and the expression of the immunoregulatory ligand, PD-L1, was not enhanced suggesting that macrophage expressed PD-L1 may be one of the ways in which MIS416-induced IFN-γ altered EAE. While NO was found to contribute to the MIS416-mediated suppression of T cell proliferation ex vivo and IFN-γ-/- mice did not have elevated levels of NO, the in vivo inhibition of iNOS by aminoguanidine did not ablate MIS416 protection suggesting that these pathways were not central to disease protection. Additionally, MIS416 treatment was shown to increase the number and function of Tregs, and in the absence of IFN-γ this expansion was reduced. Altogether, this research indicated that IFN-γ was key to MIS416-mediated protection possibly through an expansion of immunoregulatory macrophage populations, enhanced PD-L1 expression, and enhanced Treg numbers and function. In addition to these peripheral immune effects, we found that MIS416 treatment also altered cellular trafficking to the CNS. MIS416-treated EAE mice had reduced CNS infiltration as measured by both flow cytometry and histology compared to untreated EAE mice, and MIS416 treatment also reduced the EAE-induced permeability of the blood brain barrier. Furthermore, our study determined that MIS416-induced trafficking of immune cells to the CNS in the absence of EAE, and this trafficking also occurred in an IFN-γ-dependent manner. Given the suppressive nature of cells found within the periphery of MIS416-treated mice, the cells which trafficked to the CNS in response to MIS416 treatment may have had beneficial roles in EAE by suppressing T cell responses from within the CNS. In summary, the work outlined in this thesis revealed that MIS416 treatment induced an immunoregulatory state that was capable of suppressing T cell proliferation and reducing EAE disease. Moreover, this research highlighted that in the right context, a pro-inflammatory cytokine such as IFN-γ may be protective in autoimmune disease. Finally, when these findings are applied more widely, they indicate that the immune modulations induced by MIS416 may have potential in other diseases mediated by immune dysregulation in addition to MS.</p>" @default.
- W995825909 created "2016-06-24" @default.
- W995825909 creator A5091159076 @default.
- W995825909 date "2021-11-15" @default.
- W995825909 modified "2023-10-12" @default.
- W995825909 title "Innate immunomodulation with MIS416: mechanism of action in experimental autoimmune encephalomyelitis" @default.
- W995825909 cites W102576517 @default.
- W995825909 cites W1487241851 @default.
- W995825909 cites W1527404918 @default.
- W995825909 cites W1536028944 @default.
- W995825909 cites W1542844386 @default.
- W995825909 cites W1547450219 @default.
- W995825909 cites W1555151769 @default.
- W995825909 cites W1562596604 @default.
- W995825909 cites W1572252257 @default.
- W995825909 cites W1579094233 @default.
- W995825909 cites W1599776525 @default.
- W995825909 cites W1607206274 @default.
- W995825909 cites W1631600460 @default.
- W995825909 cites W1655860314 @default.
- W995825909 cites W1815871827 @default.
- W995825909 cites W1867019379 @default.
- W995825909 cites W1893566975 @default.
- W995825909 cites W1918941126 @default.
- W995825909 cites W1942668068 @default.
- W995825909 cites W1959664751 @default.
- W995825909 cites W1960519582 @default.
- W995825909 cites W1966158726 @default.
- W995825909 cites W1967261754 @default.
- W995825909 cites W1968697332 @default.
- W995825909 cites W1970841758 @default.
- W995825909 cites W1971449558 @default.
- W995825909 cites W1971514874 @default.
- W995825909 cites W1972922050 @default.
- W995825909 cites W1976397405 @default.
- W995825909 cites W1983415909 @default.
- W995825909 cites W1987479248 @default.
- W995825909 cites W1989217326 @default.
- W995825909 cites W1992851412 @default.
- W995825909 cites W2002726823 @default.
- W995825909 cites W2006632373 @default.
- W995825909 cites W2007276510 @default.
- W995825909 cites W2007360114 @default.
- W995825909 cites W2007536025 @default.
- W995825909 cites W2008399822 @default.
- W995825909 cites W2009523307 @default.
- W995825909 cites W2010057339 @default.
- W995825909 cites W2011973188 @default.
- W995825909 cites W2012628829 @default.
- W995825909 cites W2012956062 @default.
- W995825909 cites W2013187177 @default.
- W995825909 cites W2014167332 @default.
- W995825909 cites W2014323783 @default.
- W995825909 cites W2016293419 @default.
- W995825909 cites W2016964866 @default.
- W995825909 cites W2018226150 @default.
- W995825909 cites W2018968534 @default.
- W995825909 cites W2019279852 @default.
- W995825909 cites W2019535758 @default.
- W995825909 cites W2022430924 @default.
- W995825909 cites W2023096718 @default.
- W995825909 cites W2024061399 @default.
- W995825909 cites W2029739876 @default.
- W995825909 cites W2029906813 @default.
- W995825909 cites W2031501484 @default.
- W995825909 cites W2033354139 @default.
- W995825909 cites W2033970156 @default.
- W995825909 cites W2034203371 @default.
- W995825909 cites W2043992563 @default.
- W995825909 cites W2045331716 @default.
- W995825909 cites W2049372707 @default.
- W995825909 cites W2050447678 @default.
- W995825909 cites W2050707975 @default.
- W995825909 cites W2053366731 @default.
- W995825909 cites W2053547256 @default.
- W995825909 cites W2055155827 @default.
- W995825909 cites W2055521433 @default.
- W995825909 cites W2059012075 @default.
- W995825909 cites W2060109120 @default.
- W995825909 cites W2061671382 @default.
- W995825909 cites W2063516590 @default.
- W995825909 cites W2063929317 @default.
- W995825909 cites W2067780722 @default.
- W995825909 cites W2068089627 @default.
- W995825909 cites W2072448714 @default.
- W995825909 cites W2073904363 @default.
- W995825909 cites W2076889715 @default.
- W995825909 cites W2077812123 @default.
- W995825909 cites W2078534814 @default.
- W995825909 cites W2083198686 @default.
- W995825909 cites W2083770877 @default.
- W995825909 cites W2089929836 @default.
- W995825909 cites W2091092250 @default.
- W995825909 cites W2093455511 @default.
- W995825909 cites W2093636423 @default.
- W995825909 cites W2096569053 @default.
- W995825909 cites W2097021075 @default.
- W995825909 cites W2101235030 @default.
- W995825909 cites W2101937547 @default.
- W995825909 cites W2103735815 @default.